OPALINE : A Study Of Morbidity And Mortality At 2 Years

Clinical trial NCT02264665 · COMPLETED

Trial details

NCT number: NCT02264665
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive

Start date: 2015-05-12
Primary completion: 2019-11-18
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.